Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Prognostic factors in patients with pulmonary metastases (PM) from colorectal cancer (CRC) are still controversial. This study assessed oncologic outcomes and prognostic factors in patients with metachronous PM from CRC. Materials and Methods Between June 2003 and December 2011, 122 patients with CRC underwent curative resection of PM detected at least 4 months after CRC resection. Clinico-pathological factors selected from the prospectively maintained database were analyzed retrospectively. Results The median disease-free interval (DFI) between resection of the primary tumor and detection of PM was 22.0 months (range, 4 to 85 months). Solitary PM were detected in 77 patients (63.1%), with a median maximal tumor diameter of 12.0 mm (range, 2 to 70 mm). Of 52 patients who underwent mediastinal lymph node (LN) dissection, eight patients had LN involvement. Five-year overall survival and disease-free survival (DFS) rates after initial pulmonary metastasectomy were 66.4% and 50.9%, respectively. DFI, mediastinal LN involvement, and the number and distribution of PM were significantly prognostic factors for DFS. In multivariable analysis DFI 12 months, solitary lesion, and absence of mediastinal LN involvement were independently prognostic for DFS. Of the 122 patients, 48 patients (39.3%) developed recurrent PM a median 13.0 months after initial pulmonary metastasectomy. Recurrent DFI was independently prognostic of DFS in patients who underwent repeated pulmonary metastasectomy. Conclusion There is a potential survival benefit for patients with metachronous PM from CRC who undergo pulmonary metastasectomy, even those with recurrent PM. Pulmonary metastasectomy should be considered in selected patients, particularly those with longer DFI, solitary lesions, and absence of mediastinal LN involvement.
Abstract
Purpose Prognostic factors in patients with pulmonary metastases (PM) from colorectal cancer (CRC) are still controversial. This study assessed oncologic outcomes and prognostic factors in patients with metachronous PM from CRC. Materials and Methods Between June 2003 and December 2011, 122 patients with CRC underwent curative resection of PM detected at least 4 months after CRC resection. Clinico-pathological factors selected from the prospectively maintained database were analyzed retrospectively. Results The median disease-free interval (DFI) between resection of the primary tumor and detection of PM was 22.0 months (range, 4 to 85 months). Solitary PM were detected in 77 patients (63.1%), with a median maximal tumor diameter of 12.0 mm (range, 2 to 70 mm). Of 52 patients who underwent mediastinal lymph node (LN) dissection, eight patients had LN involvement. Five-year overall survival and disease-free survival (DFS) rates after initial pulmonary metastasectomy were 66.4% and 50.9%, respectively. DFI, mediastinal LN involvement, and the number and distribution of PM were significantly prognostic factors for DFS. In multivariable analysis DFI 12 months, solitary lesion, and absence of mediastinal LN involvement were independently prognostic for DFS. Of the 122 patients, 48 patients (39.3%) developed recurrent PM a median 13.0 months after initial pulmonary metastasectomy. Recurrent DFI was independently prognostic of DFS in patients who underwent repeated pulmonary metastasectomy. Conclusion There is a potential survival benefit for patients with metachronous PM from CRC who undergo pulmonary metastasectomy, even those with recurrent PM. Pulmonary metastasectomy should be considered in selected patients, particularly those with longer DFI, solitary lesions, and absence of mediastinal LN involvement.
참고문헌 (25)
- Gatta G, "Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group", Eur J Cancer, 34, pp.2176~2183 (1998)
- Zink S, "Survival, disease-free interval, and associated tumor features in patients with colon", rectal carcinomas and their resected intra-pulmonary metastases, 2001, pp.19, 908~913
- August DA, "Clinical perspective of human colorectal cancer metastasis", Cancer Metastasis Rev, 3, pp.303~324 (1984)
- McCormack PM, "Lung resection for colorectal metastases : 10-year results", Arch Surg, 127, pp.1403~1406 (1992)
- Iwasaki A, "Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer", Thorac Cardiovasc Surg, 53, pp.358~364 (2005)
- Inoue M, "Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma", Ann Thorac Surg, 78, pp.238~244 (2004)
- Girard P, "Surgery for lung metastases from colorectal cancer : analysis of prognostic factors", J Clin Oncol, 14, pp.2047~2053 (1996)
- Vogelsang H, "Factors influencing survival after resection of pulmonary metastases from colorectal cancer", Br J Surg, 91, pp.1066~1071 (2004)
- Simmonds PC, "Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group", BMJ, 321, pp.531~535 (2000)
- Seymour MT, "Attitudes and practice in the management of metastatic colorectal cancer in Britain. Colorectal Cancer Working Party of the UK Medical Research Council", Clin Oncol (R Coll Radiol), 9, pp.248~251 (1997)
- "NCCN guidelines version 3. Colon Cancer" (2013)[URL]
- Wolpin BM, "Systemic treatment of colorectal cancer", Gastroenterology, 134, pp.1296~1310 (2008)
- Saito Y, "Pulmonary metastasectomy for 165 patients with colorectal carcinoma : a prognostic assessment", J Thorac Cardiovasc Surg, 124, pp.1007~1013 (2002)
- Rena O, "Pulmonary resection for metastases from colorectal cancer : factors influencing prognosis : twenty-year experience", Eur J Cardiothorac Surg, 21, pp.906~912 (2002)
- Mitry E, "Epidemiology, management and prognosis of colorectal cancer with lung metastases : a 30-year population-based study", Gut, 59, pp.1383~1388 (2010)
- Cho S, "Prognostic factors of pulmonary metastasis from colorectal carcinoma", Interact Cardiovasc Thorac Surg, 17, pp.303~307 (2013)
- Park JS, "Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer", Ann Oncol, 21, pp.1285~1289 (2010)
- Simmonds PC, "Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies", Br J Cancer, 94, pp.982~999 (2006)
- Pfannschmidt J, "Surgical resection of pulmonary metastases from colorectal cancer : a systematic review of published series", Ann Thorac Surg, 84, pp.324~338 (2007)
- Sakamoto T, "Pulmonary resection for metastases from colorectal cancer", Chest, 119, pp.1069~1072 (2001)
- Salah S, "Repeated resection of colorectal cancer pulmonary oligometastases : pooled analysis and prognostic assessment", Ann Surg Oncol, 20, pp.1955~1961 (2013)
- Chen F, "Repeat resection of pulmonary metastasis is beneficial for patients with colorectal carcinoma", World J Surg, 34, pp.2373~2378 (2010)
- Welter S, "Long-term survival after repeated resection of pulmonary metastases from colorectal cancer", Ann Thorac Surg, 84, pp.203~210 (2007)
- Riquet M, "Pulmonary resection for metastases of colorectal adenocarcinoma", Ann Thorac Surg, 89, pp.375~380 (2010)
- Murata K, "Pulmonary metastatic nodules : CT-pathologic correlation", Radiology, 182, pp.331~335 (1992)